Apogee Therapeutics (APGE) Other Working Capital Changes (2024 - 2026)
Apogee Therapeutics' (APGE) quarterly Other Working Capital Changes came in at -$802000.0 in Q1 2026, up 20.91% year-on-year from -$663318.1 in Q1 2025, and up 20.12% on a QoQ basis from -$1.0 million in Q4 2025.
Apogee Therapeutics (APGE) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 3 years of Other Working Capital Changes data on file, last reported at -$802000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 20.91% year-over-year to -$802000.0 in Q1 2026; TTM through Mar 2026 was -$3.8 million, a 109.86% decrease from a year earlier, with the FY2025 full-year figure at -$4.0 million, down 280.96% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$802000.0, up from -$1.0 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for APGE reached as high as -$229000.0 in Q3 2024 and fell as low as -$1.0 million in Q1 2025.
- Historically, Other Working Capital Changes has averaged -$647555.6 across 3 years, with a median of -$802000.0 in 2026.
- Across the five-year window, Other Working Capital Changes plunged 333.19% in 2025 and grew 20.91% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at -$309000.0 in 2024, then slumped by 224.92% to -$1.0 million in 2025, then grew by 20.12% to -$802000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$802000.0 in Q1 2026, -$1.0 million in Q4 2025, and -$992000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Apogee Therapeutics | 9.35 Bn | 8.29 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -802,000.00 |
| Mar 31, 2026 | -802,000.00 |
| Mar 31, 2026 | -802,000.00 |
| Dec 31, 2025 | -1.00 Mn |
| Dec 31, 2025 | -1.00 Mn |
| Dec 31, 2025 | -1.00 Mn |
| Sep 30, 2025 | -992,000.00 |
| Sep 30, 2025 | -992,000.00 |
| Sep 30, 2025 | -992,000.00 |
| Jun 30, 2025 | -971,000.00 |
| Jun 30, 2025 | -971,000.00 |
| Jun 30, 2025 | -971,000.00 |
| Mar 31, 2025 | -1.01 Mn |
| Mar 31, 2025 | -1.01 Mn |
| Mar 31, 2025 | -1.01 Mn |
| Dec 31, 2024 | -309,000.00 |
| Dec 31, 2024 | -309,000.00 |
| Dec 31, 2024 | -309,000.00 |
| Sep 30, 2024 | -229,000.00 |
| Sep 30, 2024 | -229,000.00 |